TY - JOUR
T1 - American Association of Clinical Endocrinology Clinical Practice Guideline
T2 - Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
AU - Blonde, Lawrence
AU - Umpierrez, Guillermo E.
AU - Reddy, S. Sethu
AU - McGill, Janet B.
AU - Berga, Sarah L.
AU - Bush, Michael
AU - Chandrasekaran, Suchitra
AU - DeFronzo, Ralph A.
AU - Einhorn, Daniel
AU - Galindo, Rodolfo J.
AU - Gardner, Thomas W.
AU - Garg, Rajesh
AU - Garvey, W. Timothy
AU - Hirsch, Irl B.
AU - Hurley, Daniel L.
AU - Izuora, Kenneth
AU - Kosiborod, Mikhail
AU - Olson, Darin
AU - Patel, Shailendra B.
AU - Pop-Busui, Rodica
AU - Sadhu, Archana R.
AU - Samson, Susan L.
AU - Stec, Carla
AU - Tamborlane, William V.
AU - Tuttle, Katherine R.
AU - Twining, Christine
AU - Vella, Adrian
AU - Vellanki, Priyathama
AU - Weber, Sandra L.
N1 - Publisher Copyright:
© 2022 AACE
PY - 2022/10
Y1 - 2022/10
N2 - Objective: The objective of this clinical practice guideline is to provide updated and new evidence-based recommendations for the comprehensive care of persons with diabetes mellitus to clinicians, diabetes-care teams, other health care professionals and stakeholders, and individuals with diabetes and their caregivers. Methods: The American Association of Clinical Endocrinology selected a task force of medical experts and staff who updated and assessed clinical questions and recommendations from the prior 2015 version of this guideline and conducted literature searches for relevant scientific papers published from January 1, 2015, through May 15, 2022. Selected studies from results of literature searches composed the evidence base to update 2015 recommendations as well as to develop new recommendations based on review of clinical evidence, current practice, expertise, and consensus, according to established American Association of Clinical Endocrinology protocol for guideline development. Results: This guideline includes 170 updated and new evidence-based clinical practice recommendations for the comprehensive care of persons with diabetes. Recommendations are divided into four sections: (1) screening, diagnosis, glycemic targets, and glycemic monitoring; (2) comorbidities and complications, including obesity and management with lifestyle, nutrition, and bariatric surgery, hypertension, dyslipidemia, retinopathy, neuropathy, diabetic kidney disease, and cardiovascular disease; (3) management of prediabetes, type 2 diabetes with antihyperglycemic pharmacotherapy and glycemic targets, type 1 diabetes with insulin therapy, hypoglycemia, hospitalized persons, and women with diabetes in pregnancy; (4) education and new topics regarding diabetes and infertility, nutritional supplements, secondary diabetes, social determinants of health, and virtual care, as well as updated recommendations on cancer risk, nonpharmacologic components of pediatric care plans, depression, education and team approach, occupational risk, role of sleep medicine, and vaccinations in persons with diabetes. Conclusions: This updated clinical practice guideline provides evidence-based recommendations to assist with person-centered, team-based clinical decision-making to improve the care of persons with diabetes mellitus.
AB - Objective: The objective of this clinical practice guideline is to provide updated and new evidence-based recommendations for the comprehensive care of persons with diabetes mellitus to clinicians, diabetes-care teams, other health care professionals and stakeholders, and individuals with diabetes and their caregivers. Methods: The American Association of Clinical Endocrinology selected a task force of medical experts and staff who updated and assessed clinical questions and recommendations from the prior 2015 version of this guideline and conducted literature searches for relevant scientific papers published from January 1, 2015, through May 15, 2022. Selected studies from results of literature searches composed the evidence base to update 2015 recommendations as well as to develop new recommendations based on review of clinical evidence, current practice, expertise, and consensus, according to established American Association of Clinical Endocrinology protocol for guideline development. Results: This guideline includes 170 updated and new evidence-based clinical practice recommendations for the comprehensive care of persons with diabetes. Recommendations are divided into four sections: (1) screening, diagnosis, glycemic targets, and glycemic monitoring; (2) comorbidities and complications, including obesity and management with lifestyle, nutrition, and bariatric surgery, hypertension, dyslipidemia, retinopathy, neuropathy, diabetic kidney disease, and cardiovascular disease; (3) management of prediabetes, type 2 diabetes with antihyperglycemic pharmacotherapy and glycemic targets, type 1 diabetes with insulin therapy, hypoglycemia, hospitalized persons, and women with diabetes in pregnancy; (4) education and new topics regarding diabetes and infertility, nutritional supplements, secondary diabetes, social determinants of health, and virtual care, as well as updated recommendations on cancer risk, nonpharmacologic components of pediatric care plans, depression, education and team approach, occupational risk, role of sleep medicine, and vaccinations in persons with diabetes. Conclusions: This updated clinical practice guideline provides evidence-based recommendations to assist with person-centered, team-based clinical decision-making to improve the care of persons with diabetes mellitus.
KW - antihyperglycemic medications
KW - atherosclerotic cardiovascular disease
KW - cardiovascular diseases
KW - diabetes
KW - diabetes mellitus
KW - diabetes mellitus, type 1
KW - diabetes mellitus, type 2
KW - diabetic nephropathies
KW - diabetic neuropathies
KW - diabetic retinopathy
KW - dyslipidemias
KW - gestational
KW - guideline
KW - hospitalization
KW - hypertension
KW - hypoglycemia
KW - infertility
KW - interdisciplinary communication
KW - metabolic syndrome
KW - obesity
KW - occupations
KW - prediabetic state
KW - pregnancy
KW - secondary diabetes
KW - sleep apnea syndromes
KW - telemedicine
KW - vaccination
UR - http://www.scopus.com/inward/record.url?scp=85139279760&partnerID=8YFLogxK
U2 - 10.1016/j.eprac.2022.08.002
DO - 10.1016/j.eprac.2022.08.002
M3 - Article
C2 - 35963508
AN - SCOPUS:85139279760
SN - 1530-891X
VL - 28
SP - 923
EP - 1049
JO - Endocrine Practice
JF - Endocrine Practice
IS - 10
ER -